Melisa Wong Points Out Potential Age Bias in Active Treatment of Lung Cancer

Video

Melisa Wong lays out the findings of a study she did looking at the age of patients with recurrent lung cancer and the likelihood they were to receive active treatment.

Melisa Wong, MD, of the University of California, San Francisco, lays out the findings of a study she did looking at the age of patients with recurrent lung cancer and the likelihood they were to receive active treatment.

The study found that for every 10-year increase in age, a patient was 25% less likely to receive active care—a patient aged 70 years was 25% more likely than one aged 80 to receive active treatment for their cancer. She suggests that age bias, among other reasons, could be responsible for this gap.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with blonde hair wearing a denim jacket in front of a blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop